Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma

[1]  Susan M. Chang,et al.  A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets , 2022, Nature cancer.

[2]  P. Kubes,et al.  Neutrophil phenotypes and functions in cancer: A consensus statement , 2022, The Journal of experimental medicine.

[3]  S. Horswell,et al.  Radiation exposure elicits a neutrophil-driven response in healthy lung tissue that enhances metastatic colonization , 2022, Nature Cancer.

[4]  M. Lim,et al.  Roles of Neutrophils in Glioma and Brain Metastases , 2021, Frontiers in Immunology.

[5]  N. Shomron,et al.  Exploring the longitudinal glioma microenvironment landscape uncovers reprogrammed pro-tumorigenic neutrophils in the bone marrow. , 2021, Cell reports.

[6]  Qianghu Wang,et al.  Chitinase-3-like-1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma. , 2021, The Journal of clinical investigation.

[7]  A. Regev,et al.  Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma. , 2021, Cancer cell.

[8]  Zhihong Chen,et al.  Macrophage-tumor cell intertwine drives the transition into a mesenchymal-like cellular state of glioblastoma. , 2021, Cancer cell.

[9]  Jaclyn N. Taroni,et al.  Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality , 2021, Cell reports.

[10]  D. Hambardzumyan,et al.  Macrophages and microglia: the cerberus of glioblastoma , 2021, Acta neuropathologica communications.

[11]  J. Egen,et al.  Activity of tumor-associated macrophage depletion by CSF1R blockade is highly dependent on the tumor model and timing of treatment , 2021, Cancer Immunology, Immunotherapy.

[12]  Gary D Bader,et al.  Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity , 2021, Nature Cancer.

[13]  A. Joyner,et al.  CSF1R Inhibition Depletes Tumor-Associated Macrophages and Attenuates Tumor Progression in a Mouse Sonic Hedgehog-Medulloblastoma Model , 2020, Oncogene.

[14]  B. Zacharia,et al.  Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression , 2020, Nature Communications.

[15]  J. Westerga,et al.  Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance , 2020, Science Translational Medicine.

[16]  Megan L. Wojciechowicz,et al.  Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade. , 2020, Glia.

[17]  M. Pittet,et al.  Durable and controlled depletion of neutrophils in mice , 2020, Nature Communications.

[18]  J. Hartley,et al.  The Frequency of Ras Mutations in Cancer , 2020, Cancer Research.

[19]  Mirjana Efremova,et al.  CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes , 2020, Nature Protocols.

[20]  Arnold Kriegstein,et al.  The phenotypes of proliferating glioblastoma cells reside on a single axis of variation. , 2019, Cancer discovery.

[21]  D. Brat,et al.  Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors , 2019, Oncoimmunology.

[22]  Mariella G. Filbin,et al.  An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma , 2019, Cell.

[23]  Zhihong Chen,et al.  Intravital 2-photon imaging reveals distinct morphology and infiltrative properties of glioblastoma-associated macrophages , 2019, Proceedings of the National Academy of Sciences.

[24]  T. MacDonald,et al.  Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma , 2019, Nature Communications.

[25]  T. MacDonald,et al.  Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma , 2019, Nature Communications.

[26]  Jun Li,et al.  Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma. , 2019, Cancer cell.

[27]  L. Cerchia,et al.  Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma , 2019, International journal of molecular sciences.

[28]  S. Robinson,et al.  CXCR2 Blockade Mitigates Neural Cell Injury Following Preclinical Chorioamnionitis , 2019, Front. Physiol..

[29]  R. Verhaak,et al.  Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target , 2018, The Journal of clinical investigation.

[30]  R. Alon,et al.  Distinct Compartmentalization of the Chemokines CXCL1 and CXCL2 and the Atypical Receptor ACKR1 Determine Discrete Stages of Neutrophil Diapedesis , 2018, Immunity.

[31]  Edward F. Chang,et al.  Erratum: Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment (Cancer Cell (2017) 32(1) (42–56.e6)(S1535610817302532)(10.1016/j.ccell.2017.06.003)) , 2018 .

[32]  Caroline L. Wilson,et al.  Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma? , 2017, British Journal of Cancer.

[33]  K. Sun,et al.  Therapeutic inhibition of CXC chemokine receptor 2 by SB225002 attenuates LPS-induced acute lung injury in mice , 2017, Archives of medical science : AMS.

[34]  P. Hinds.  Faculty Opinions recommendation of Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma. , 2017 .

[35]  Chunsheng Zhang,et al.  Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors. , 2017, Cancer cell.

[36]  C. Brennan,et al.  Genetic driver mutations define the expression signature and microenvironmental composition of high‐grade gliomas , 2017, Glia.

[37]  William Ritchie,et al.  A Liver Capsular Network of Monocyte‐Derived Macrophages Restricts Hepatic Dissemination of Intraperitoneal Bacteria by Neutrophil Recruitment , 2017, Immunity.

[38]  Steven J. M. Jones,et al.  Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma , 2017, Cell.

[39]  Zhihong Chen,et al.  Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma. , 2017, Cancer research.

[40]  J. Llovet,et al.  Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma , 2016, Gut.

[41]  R. Ransohoff,et al.  Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus , 2016, Proceedings of the National Academy of Sciences.

[42]  L. Mirny,et al.  Hematopoietic Stem Cells Are the Major Source of Multilineage Hematopoiesis in Adult Animals. , 2016, Immunity.

[43]  A. Biankin,et al.  CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma , 2016, Cancer cell.

[44]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[45]  R. Stupp,et al.  Corticosteroids compromise survival in glioblastoma. , 2016, Brain : a journal of neurology.

[46]  M. Prados,et al.  Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study. , 2016, Neuro-oncology.

[47]  Ginu A. Thomas,et al.  Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. , 2016, JCI insight.

[48]  R. Muschel,et al.  Targeting the CCL2-CCR2 signaling axis in cancer metastasis , 2016, Oncotarget.

[49]  G. Stragliotto,et al.  Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients , 2016, Oncoimmunology.

[50]  L. Rénia,et al.  Neutrophils Self-Regulate Immune Complex-Mediated Cutaneous Inflammation through CXCL2. , 2016, The Journal of investigative dermatology.

[51]  [World Health Organization classification of tumours of the central nervous system: a summary]. , 2016, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[52]  Helmut Kettenmann,et al.  The role of microglia and macrophages in glioma maintenance and progression , 2015, Nature Neuroscience.

[53]  G. Bergers,et al.  Glioblastoma: Defining Tumor Niches. , 2015, Trends in cancer.

[54]  Zhihong Chen,et al.  Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis , 2015, Oncotarget.

[55]  Carlos J. Madrid-Aliste,et al.  Buprenorphine Decreases the CCL2-Mediated Chemotactic Response of Monocytes , 2015, The Journal of Immunology.

[56]  C. Brennan,et al.  Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma , 2014, Clinical Cancer Research.

[57]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[58]  D. Calvisi,et al.  Hydrodynamic transfection for generation of novel mouse models for liver cancer research. , 2014, The American journal of pathology.

[59]  E. Holland,et al.  In vivo radiation response of proneural glioma characterized by protective p53 transcriptional program and proneural-mesenchymal shift , 2014, Proceedings of the National Academy of Sciences.

[60]  C. Brennan,et al.  Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates , 2013, Acta Neuropathologica.

[61]  G. Fuller,et al.  Neutrophils Promote the Malignant Glioma Phenotype through S100A4 , 2013, Clinical Cancer Research.

[62]  D. Haussler,et al.  The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.

[63]  Bernard Malissen,et al.  Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF , 2013, The Journal of experimental medicine.

[64]  Christina S. Leslie,et al.  CSF-1R inhibition alters macrophage polarization and blocks glioma progression , 2013, Nature Medicine.

[65]  Se Hoon Kim,et al.  Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. , 2013, Cancer cell.

[66]  N. Hogg,et al.  PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS Mast cell and macrophage chemokines CXCL 1 / CXCL 2 control the early stage of neutrophil recruitment during tissue in fl ammation , 2013 .

[67]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[68]  V. P. Collins,et al.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.

[69]  A. Mildner,et al.  Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. , 2013, Immunity.

[70]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[71]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[72]  F. Bushman,et al.  Cxcr2 and Cxcl5 regulate the IL-17/G-CSF axis and neutrophil homeostasis in mice. , 2012, The Journal of clinical investigation.

[73]  R. Ransohoff,et al.  The Fractalkine Receptor but Not CCR2 Is Present on Microglia from Embryonic Development throughout Adulthood , 2012, The Journal of Immunology.

[74]  Patrick S. Aranda,et al.  Bleach gel: A simple agarose gel for analyzing RNA quality , 2012, Electrophoresis.

[75]  Avner Schlessinger,et al.  ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI , 2012 .

[76]  B. Kleinschmidt-DeMasters,et al.  Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I. , 2011, Clinical cancer research : an official journal of the American Association for Cancer Research.

[77]  Xiao‐Yu Yin,et al.  Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. , 2011, Journal of hepatology.

[78]  F. Ginhoux,et al.  Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.

[79]  Edward R. Kastenhuber,et al.  Role of Type 1 IFNs in Antiglioma Immunosurveillance—Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans , 2010, Clinical Cancer Research.

[80]  R. Ransohoff,et al.  Monocytes Regulate T Cell Migration through the Glia Limitans during Acute Viral Encephalitis , 2010, Journal of Virology.

[81]  C. Brennan,et al.  Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. , 2010, Cell stem cell.

[82]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[83]  Magali Olivier,et al.  TP53 mutations in human cancers: origins, consequences, and clinical use. , 2010, Cold Spring Harbor perspectives in biology.

[84]  P. Chambon,et al.  Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network , 2009, The Journal of experimental medicine.

[85]  P. Libby,et al.  Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites , 2009, Science.

[86]  Tatsuya Ozawa,et al.  PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. , 2009, Cell stem cell.

[87]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[88]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[89]  M. J. Cody,et al.  Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-α), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis , 2008, Innate immunity.

[90]  F. Rossi,et al.  Local self-renewal can sustain CNS microglia maintenance and function throughout adult life , 2007, Nature Neuroscience.

[91]  D. Tuveson,et al.  Dynamics of the immune reaction to pancreatic cancer from inception to invasion. , 2007, Cancer research.

[92]  M. Siemionow,et al.  TNF-α receptor-II is required for TNF-α- induced leukocyte-endothelial interaction in vivo , 2006 .

[93]  J. Shinoda,et al.  Molecular mechanisms of TNF-α-induced ceramide formation in human glioma cells:P53-mediated oxidant stress-dependent and -independent pathways , 2004, Cell Death and Differentiation.

[94]  R. Moots,et al.  Granulocyte Macrophage Colony-stimulating Factor Signaling and Proteasome Inhibition Delay Neutrophil Apoptosis by Increasing the Stability of Mcl-1* , 2004, Journal of Biological Chemistry.

[95]  D. Bar-Sagi,et al.  Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. , 2004, Cancer cell.

[96]  M. Burdick,et al.  Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. , 2002, The Journal of clinical investigation.

[97]  I. Weissman,et al.  Langerhans cells renew in the skin throughout life under steady-state conditions , 2002, Nature Immunology.

[98]  A. Proudfoot.  Chemokine receptors: multifaceted therapeutic targets , 2002, Nature Reviews Immunology.

[99]  R. Hertzberg,et al.  Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration* , 1998, The Journal of Biological Chemistry.

[100]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[101]  B. Trapp,et al.  Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes. , 1996, The Journal of clinical investigation.

[102]  R. Bravo,et al.  Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. , 1995, Journal of immunology.

[103]  J. Trosko,et al.  AN INTEGRATIVE MODEL , 1978 .